Literature DB >> 17880573

No association of the -105 promoter polymorphism of the selenoprotein S encoding gene SEPS1 with cerebrovascular disease.

S Hyrenbach1, A Pezzini, E del Zotto, A Giossi, C Lichy, M Kloss, I Werner, A Padovani, T Brandt, C Grond-Ginsbach.   

Abstract

A common pro-inflammatory promoter variant of the selenoprotein S encoding gene (SEPS1) was studied in young stroke patients from Italy and Germany and in healthy control subjects. The -105A-allele was found in 56 of 205 (27.3%) patients with ischemic stroke IS because of a spontaneous cervical artery dissection (CAD), and in 69 of 295 (23.4%) patients <50 years with IS of non-CAD origin. The SEPS -105A promoter variant was detected in 87 of 393 healthy control subjects (22.1%) and in 11 of 55 CAD patients without IS (20%). The non-significant differences of SEPS1 allele frequencies between disease groups and healthy controls suggest that the SEPS1 -105A allele is not a major-risk factor for stroke.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880573     DOI: 10.1111/j.1468-1331.2007.01898.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  9 in total

1.  Association studies of SEPS1 gene polymorphisms with Hashimoto's thyroiditis in Han Chinese.

Authors:  Miao Li; Bailing Liu; Lu Li; Chen Zhang; Qi Zhou
Journal:  J Hum Genet       Date:  2015-05-28       Impact factor: 3.172

2.  Polymorphisms in the Selenoprotein S gene and subclinical cardiovascular disease in the Diabetes Heart Study.

Authors:  Amanda J Cox; Allison B Lehtinen; Jianzhao Xu; Carl D Langefeld; Barry I Freedman; J Jeffrey Carr; Donald W Bowden
Journal:  Acta Diabetol       Date:  2012-11-16       Impact factor: 4.280

3.  Association analysis of selenoprotein S polymorphisms in Chinese Han with susceptibility to gastric cancer.

Authors:  Huajie Mao; Ruifang Cui; Xiaochun Wang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  Molecular characterization and NF-κB-regulated transcription of selenoprotein S from the Bama mini-pig.

Authors:  Ningbo Zhang; Wenqian Jing; Jiayue Cheng; Wentao Cui; Yulian Mu; Kui Li; Xingen Lei
Journal:  Mol Biol Rep       Date:  2010-11-30       Impact factor: 2.316

Review 5.  Regulation and function of selenoproteins in human disease.

Authors:  Frederick P Bellinger; Arjun V Raman; Mariclair A Reeves; Marla J Berry
Journal:  Biochem J       Date:  2009-07-29       Impact factor: 3.857

6.  SEPS1 gene is activated during astrocyte ischemia and shows prominent antiapoptotic effects.

Authors:  Noelia Fradejas; María Dolores Pastor; Silvia Mora-Lee; Pedro Tranque; Soledad Calvo
Journal:  J Mol Neurosci       Date:  2008-05-23       Impact factor: 3.444

Review 7.  Selenoprotein S: a therapeutic target for diabetes and macroangiopathy?

Authors:  Shan-Shan Yu; Jian-Ling Du
Journal:  Cardiovasc Diabetol       Date:  2017-08-10       Impact factor: 9.951

8.  Selenoprotein S (SEPS1) gene -105G>A promoter polymorphism influences the susceptibility to gastric cancer in the Japanese population.

Authors:  Tomoyuki Shibata; Tomiyasu Arisawa; Tomomitsu Tahara; Masaaki Ohkubo; Daisuke Yoshioka; Naoko Maruyama; Hiroshi Fujita; Yoshio Kamiya; Masakatsu Nakamura; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Ichiro Hirata
Journal:  BMC Gastroenterol       Date:  2009-01-13       Impact factor: 3.067

9.  Polymorphisms in the selenoprotein S gene: lack of association with autoimmune inflammatory diseases.

Authors:  Alfonso Martínez; Jose Luis Santiago; Jezabel Varadé; Ana Márquez; José Ramón Lamas; Juan Luis Mendoza; Hermenegildo de la Calle; Manuel Díaz-Rubio; Emilio G de la Concha; Benjamín Fernández-Gutiérrez; Elena Urcelay
Journal:  BMC Genomics       Date:  2008-07-14       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.